PSA 4.1 – 6.0 ng/ml

Gleason Score

Path Stage

Clinical Stage

T1c

T2a

T2b

T2c

2-4

OC

90

78-98

81

63-95

75

55-93

73

52-93

CP

10

2-22

19

5-37

25

7-45

27

7-48

SV+

0

0-0

0

0-0

0

0-0

0

0-0

LN+

0

0-0

0

0-0

0

0-0

0

0-0

5-6

OC

80

78-83

66

62-70

57

52-63

55

44-64

CP

19

16-21

32

28-36

39

33-44

40

32-50

SV+

1

0-1

1

1-2

2

1-3

2

1-4

LN+

0

0-1

1

0-2

2

1-3

3

1-7

3+4=7

OC

63

58-68

44

39-50

35

29-40

31

23-41

CP

32

27-36

46

40-52

51

44-57

50

40-60

SV+

3

2-5

5

3-8

7

4-11

6

2-11

LN+

2

1-3

4

2-7

7

4-13

12

5-23

4+3=7

OC

52

43-60

33

254-41

25

18-32

21

14-31

CP

42

35-50

56

48-64

60

50-68

57

43-68

SV+

3

1-6

5

2-8

5

3-9

4

1-10

LN+

3

1-5

6

3-11

10

5-18

16

6-32

8-10

OC

46

36-56

28

20-37

21

14-29

18

11-28

CP

45

36-54

58

49-66

59

49-69

57

43-70

SV+

5

3-9

8

4-13

9

4-16

7

2-15

LN+

3

1-6

6

2-12

10

4-20

16

6-33